SURGICAL THERAPY FOR TYPE-2 DIABETES: ARE WE MISSING A GOLDEN OPPORTUNITY FOR BETTER CARE

Abstract
With the growing epidemics of obesity and type-2 diabetes it is important to seek effective therapy. Obesity surgery provides unparallel efficacy in the treatment of the severely obese patient with diabetes, providing remission of diabetes in the majority of subjects. However, it is rarely used or recommended. This article explores the evidence for surgical therapy and provides a compelling argument for early intervention.

Key words
Type-2 diabetes, obesity, obesity surgery

Bibliografía del artículo

1. Mokdad AH, Bowman BA, Ford ES, Vinicor F, Marks JS, Koplan JP. The continuing epidemics of obesity and diabetes in the United States. JAMA 2001;286:1195-200.
2. Mokdad AH, Ford ES, Bowman BA et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 2003;289:76-9.
3. Leibson CL, Williamson DF, Melton LJ, 3rd et al. Temporal trends in BMI among adults with diabetes. Diabetes Care 2001;24:1584-9.
4. Hogan P, Dall T, Nikolov P. Economic costs of diabetes in the US in 2002. Diabetes Care 2003;26:917-32.
5. Tuomilehto J, Lindstrom J, Eriksson JG et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001;344:1343-50.
6. Eriksson KF, Lindgarde F. Prevention of type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise. The 6-year Malmo feasibility study. Diabetologia 1991;34:891-8.
7. Wing RR, Marcus MD, Epstein LH, Salata R. Type II diabetic subjects lose less weight than their overweight nondiabetic spouses. Diabetes Care 1987;10:563-6.
8. Khan MA, St. Peter JV, Breen GA, Hartley GG, Vessey JT. Diabetes disease stage predicts weight loss outcomes with long-term appetite suppressants. Obes Res 2000;8:43-8.
9. Dixon JB, Dixon ME, O'Brien PE. Pre-operative predictors of weight loss at 1-year after Lap-Band surgery. Obes Surg 2001;11:200-7.
10. Williamson DF, Thompson TJ, Thun M, Flanders D, Pamuk E, Byers T. Intentional weight loss and mortality among overweight individuals with diabetes. Diabetes Care 2000;23:1499-504.
11. MacDonald KG, Jr., Long SD, Swanson MS et al. The Gastric Bypass Operation Reduces the Progression and Mortality of Non-Insulin-Dependent Diabetes Mellitus. J Gastrointest Surg 1997;1:213-220.
12. Pories WJ, Swanson MS, MacDonald KG et al. Who would have thought it An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg 1995;222:339-50; discussion 350-2.
13. Pories WJ, MacDonald KG, Jr., Morgan EJ et al. Surgical treatment of obesity and its effect on diabetes: 10-y follow- up. Am J Clin Nutr 1992;55:582S-585S.
14. Torgerson JS, Sjostrom L. The Swedish Obese Subjects (SOS) study--rationale and results. Int J Obes Relat Metab Disord 2001;25 Suppl 1:S2-4.
15. Sugerman HJ, Wolfe LG, Sica DA, Clore JN. Diabetes and hypertension in severe obesity and effects of gastric bypass-induced weight loss. Annals of Surgery 2003;237:751-6; discussion 757-8.
16. Dixon JB, O'Brien P. Health Outcomes of Severely Obese Type 2 Diabetic Subjects 1 Year After Laparoscopic Adjustable Gastric Banding. Diabetes Care 2002;25:358-363.
17. Dixon JB, Dixon AF, O'Brien PE. Improvements in insulin sensitivity and beta-cell function (HOMA) with weight loss in the severely obese. Diabet Med 2003;20:127-34.
18. Dixon J, O'Brien P. Weight loss following laparoscopic adjustable gastric band surgery produces sustained improvements in fasting plasma glucose and indirect measures of insulin resistance (abstract). Diabetes 2003;52:75.
19. UKPDS16. U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. U.K. Prospective Diabetes Study Group. Diabetes 1995;44:1249-58.
20. Clauson P, Linnarsson R, Gottsater A, Sundkvist G, Grill V. Relationships between diabetes duration, metabolic control and beta- cell function in a representative population of type 2 diabetic patients in Sweden. Diabet Med 1994;11:794-801.
21. Polonsky KS, Gumbiner B, Ostrega D, Griver K, Tager H, Henry RR. Alterations in immunoreactive proinsulin and insulin clearance induced by weight loss in NIDDM. Diabetes 1994;43:871-7.
22. Gumbiner B, Van Cauter E, Beltz WF et al. Abnormalities of insulin pulsatility and glucose oscillations during meals in obese noninsulin-dependent diabetic patients: effects of weight reduction. J Clin Endocrinol Metab 1996;81:2061-8.
23. UKPDS33. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998;352:837-53.
24. UKPDS37. Quality of life in type 2 diabetic patients is affected by complications but not by intensive policies to improve blood glucose or blood pressure control (UKPDS 37). U.K. Prospective Diabetes Study Group. Diabetes Care 1999;22:1125-36.
25. UKPDS38. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. Bmj 1998;317:703-13.
26. Dixon JB, Dixon ME, O'Brien PE. Quality of life after lap-band placement: influence of time, weight loss, and comorbidities. Obes Res 2001;9:713-21.
27. Dixon JB, Dixon ME, O'Brien PE. Body image: appearance orientation and evaluation in the severely obese. Changes with weight loss. Obes Surg 2002;12:65-71.
28. Dixon JB, O'Brien PE. Lipid profile in the severely obese: changes with weight loss after lap-band surgery. Obes Res 2002;10:903-10.
29. Dixon JB, Dixon ME, O'Brien P. Depression in association with severe obesity: Changes with weighrt loss. Archives of Internal Medicine 2003;163:2058-65.

Autoevaluación